Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
J Eur Acad Dermatol Venereol ; 31(2): 260-266, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27453064

ABSTRACT

BACKGROUND: Actinic keratosis (AK) is a cutaneous intraepithelial neoplasm that typically develops on sun-damaged skin. The incidence of AK is increasing worldwide, and it is accepted as the most frequent pre-malignant lesion in humans. OBJECTIVES: To demonstrate that ingenol mebutate gel is effective in the treatment of actinic keratoses because of its clinical, dermoscopic, capillaroscopic, histopathological and immunohistochemical treatment outcomes. METHODS: Sixty individuals with multiple non-hypertrophic AKs were enrolled into this non-randomized, open-label, prospective, trial. Acquisition of clinical, dermoscopic and capillaroscopic images at baseline (T0), immediately after treatment on 3rd (trunk and/or extremities) or 4th (scalp and/or face) day (T1), 14 days after the end of the treatment (T2) and at 60 days (T3). A subgroup of 20 patients received a cutaneous biopsy both at baseline and at T3 for histological and immunohistochemical evaluation. RESULTS: Clinical improvement was observed in 100% of cases: total clearance in 41 patients (68.3%); partial clearance in 19 patients (32.7%). After treatment, dermoscopic improvement of all non-pigmented and pigmented AK lesions was observed. Most of the dermoscopic features disappeared with treatment. Total disappearance of specific vascular structures or significant reduction in the number and calibre of new blood vessels was capillaroscopically observed in all patients analysed (P ≤ 0.001). The immunohistochemical expression of p63 (P = 0.002), Ki-67 (P = 0.015) and VEGF (P = 0.016) significantly decreased. CONCLUSIONS: The clinical efficacy of ingenol mebutate on AKs is confirmed by its effect on angiogenesis, stem cell activity and cell proliferation in vivo.


Subject(s)
Dermoscopy/methods , Diterpenes/therapeutic use , Keratosis, Actinic/drug therapy , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Keratosis, Actinic/metabolism , Male , Middle Aged , Prospective Studies
2.
Dermatol Ther ; 29(5): 325-329, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27364361

ABSTRACT

Granuloma faciale (GF) is a rare chronic inflammatory dermatosis of unknown etiology, characterized by leukocitoclastic vasculitis usually occurring on the face. We report a case of 60-years-old man with 3 year history of multiple actinic keratoses (AK) and persistent asymptomatic erythematous papules and plaques located over his left temporal region and the cheek: histopathology was consistent with GF. Herein we describe the successful treatment of the lesion with ingenol mebutate 0.015% gel focusing on the clinical, dermoscopic and histopathological findings of GF both before and after treatment.


Subject(s)
Dermatologic Agents/therapeutic use , Diterpenes/therapeutic use , Facial Dermatoses/drug therapy , Granuloma/drug therapy , Keratosis, Actinic/drug therapy , Skin/drug effects , Administration, Cutaneous , Biopsy , Dermatologic Agents/administration & dosage , Dermoscopy , Diterpenes/administration & dosage , Facial Dermatoses/diagnosis , Gels , Granuloma/diagnosis , Humans , Keratosis, Actinic/diagnosis , Male , Middle Aged , Remission Induction , Skin/pathology , Treatment Outcome
3.
G Ital Dermatol Venereol ; 150(4): 467-71, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25394212

ABSTRACT

Toxic epidermal necrolysis (TEN), also known as Lyell syndrome, is a potential life-threatening muco-cutaneous disease with important systemic implications. It affects the skin and mucous membranes, with involvement of more than 30% of body surface and it is mostly caused by drugs. Although the pathogenesis is not fully elucidated, it is probably linked to the inability to detoxicate reactive metabolites of drugs, to genetic susceptibility and to immune factors leading to cellular apoptosis. Currently, there are no randomized control trials and stardardized therapeutical approaches for the management of Lyell syndrome; therefore controversial clinical responses to the most common used drug in TEN make it difficult for the clinical-therapeutic approach. The authors reported their experience on three patients affected by Lyell syndrome treated with infliximab.


Subject(s)
Dermatologic Agents/therapeutic use , Infliximab/therapeutic use , Stevens-Johnson Syndrome/drug therapy , Aged, 80 and over , Female , Humans , Male , Middle Aged , Mucous Membrane/pathology , Skin/pathology , Stevens-Johnson Syndrome/pathology , Treatment Outcome
5.
J Eur Acad Dermatol Venereol ; 20(10): 1220-5, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17062035

ABSTRACT

BACKGROUND: Merkel cell carcinoma (MCC) is a rare, aggressive cancer of the skin that mainly affects elderly patients. Because of its rarity, there is no established treatment or proven markers to guide therapy or prognosis. Immunohistochemical expression of apoptosis proteins is considered a useful marker of both malignancy and tumour progression. Apoptosis plays a fundamental role in skin homeostasis, and apoptotic cells have been detected in normal and diseased skin. Chemokines possess a wide range of biological activities and CXCR4 is expressed in some cancer cells, where it plays an efficient role in metastasis formation. OBJECTIVE: To identify immunohistochemical parameters that can help clinicians select the most suitable therapy for skin MCC. DESIGN: Antibodies against ki67, bcl-2, p53, survivin, p16 and CXCR4 were tested to assess the usefulness of these antigens as indices of proliferation potential and predictors of prognosis. METHODS: Immunohistochemical detection of apoptosis inhibitors and CXCR4 was performed on tissue from 12 patients with primary MCC. After excision of the primary lesion, five survived and had no metastases, and seven experienced local recurrence or lymph node metastases. RESULTS: Expression of ki67 and survivin was increased in patients with local recurrence or metastasis (retrospectively classified as 'poor prognosis') compared with those with a 'good prognosis', and bcl-2 expression was significantly greater (P=0.003). P53 and p16 immunostaining was moderate in both groups. A positive correlation was observed between survivin and mutant p53 in the poor prognosis group (r=0.593, P=0.033; regression coefficient). High values of p53 were measured in patients with high levels of survivin and vice versa. CXCR4 was not detected at all. CONCLUSIONS: Our results show strong MCC cell apoptosis inhibition and a high cell proliferation capacity. The positive correlation between survivin and p53 may be a predictor of MCC spread via the lymphatic network. Absent CXCR4 expression may reflect a less aggressive form, with less efficient development of distant and non-organ-selective metastasis formation.


Subject(s)
Apoptosis , Carcinoma, Merkel Cell/metabolism , Carcinoma, Merkel Cell/pathology , Receptors, CXCR4/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Biomarkers/metabolism , Biomarkers, Tumor/metabolism , Cell Division , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Humans , Immunohistochemistry , Inhibitor of Apoptosis Proteins , Ki-67 Antigen/metabolism , Microtubule-Associated Proteins/metabolism , Neoplasm Proteins/metabolism , Predictive Value of Tests , Prognosis , Proto-Oncogene Proteins c-bcl-2/metabolism , Survivin , Tumor Suppressor Protein p53/metabolism
6.
J Eur Acad Dermatol Venereol ; 19(6): 732-6, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16268881

ABSTRACT

We present a case of an intriguing mesenchymal neoplasm of the scalp that recurred several times over 10 years before a final diagnosis was possible. The case was sent for expert opinions to various international dermatopathological authorities and was, for a long time, unanimously interpreted as malignant melanoma. This diagnosis was supported by immunohistochemical examinations demonstrating S-100 positivity. Nevertheless, the clinical behaviour, as well as some histopathological features raised doubt regarding the diagnosis. Only after the last recurrence, followed by a repeat extensive immunohistochemical study, the diagnosis of epithelioid angiosarcoma was made. Histologically malignant melanoma can be highly misleading and in literature, reports of misinterpreted cases of melanoma are published. In contrast, tumours that can simulate melanoma are also not infrequent and it is essential to perform immunohistochemistry to confirm diagnosis and exclude a melanocytic lesion.


Subject(s)
Head and Neck Neoplasms/diagnosis , Hemangiosarcoma/diagnosis , Scalp/pathology , Skin Neoplasms/diagnosis , Diagnosis, Differential , Female , Head and Neck Neoplasms/pathology , Hemangiosarcoma/pathology , Humans , Melanoma/diagnosis , Middle Aged , Skin Neoplasms/pathology
8.
Urol Int ; 70(3): 227-31, 2003.
Article in English | MEDLINE | ID: mdl-12660463

ABSTRACT

A 43-year-old Albanian man is presented who underwent nephrectomy for a huge right spontaneous perirenal hematoma. The diagnosis of polyarteritis nodosa as the etiology of the hematoma has been made only by histological examination, because of the quick and unforeseeable onset of this complication and the nonspecificity of symptoms. We hypothesize a relationship between reactivation of polyarteritis nodosa and treatment with rifampicin and isoniazid.


Subject(s)
Hematoma/etiology , Hypertension, Renal/etiology , Kidney Diseases/etiology , Polyarteritis Nodosa/complications , Adult , Antitubercular Agents/therapeutic use , Humans , Isoniazid/therapeutic use , Kidney/pathology , Male , Mycobacterium Infections, Nontuberculous/drug therapy , Nephrectomy , Rifampin/therapeutic use
9.
Lupus ; 12(1): 63-6, 2003.
Article in English | MEDLINE | ID: mdl-12587829

ABSTRACT

We report on a case of 40-year-old female with systemic lupus erythematosus (SLE) who developed a severe bullous eruption on sun-exposed areas. The bullous manifestation was associated with a flare of lupus serologies, whereas the previous manifestations of the disease were quiescent. Due to prior intolerance to many drugs, she was given oral methotrexate (10 mg/week). The drug administration was followed by a rapid and full resolution of cutaneous lesions. Five months later she developed a class III lupus nephritis. Our case is the first report of efficacy of methotrexate in bullous SLE and rises the question of the relationship between bullous eruption and SLE activity.


Subject(s)
Dermatologic Agents/administration & dosage , Lupus Erythematosus, Systemic/drug therapy , Methotrexate/administration & dosage , Skin Diseases, Vesiculobullous/drug therapy , Administration, Oral , Adult , Female , Humans , Lupus Erythematosus, Systemic/pathology , Lupus Nephritis/drug therapy , Lupus Nephritis/pathology , Skin Diseases, Vesiculobullous/pathology
10.
Br J Dermatol ; 146(5): 877-81, 2002 May.
Article in English | MEDLINE | ID: mdl-12000388

ABSTRACT

We report a 22-year-old woman who developed systemic lupus erythematosus (SLE) immediately after an Epstein-Barr virus (EBV)-induced mononucleosis infection. The link between these two conditions has long been suspected. The close temporal relationship, the course of the pathological events and the development of immunological changes in this case provide further evidence supporting the hypothesis that EBV infection could work as a trigger in some cases of SLE, particularly if the patient is genetically susceptible.


Subject(s)
Infectious Mononucleosis/complications , Lupus Erythematosus, Systemic/virology , Acute Disease , Adult , Autoantibodies/blood , Female , Humans , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/pathology
11.
J Cutan Pathol ; 28(3): 120-6, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11168762

ABSTRACT

BACKGROUND: Metalloproteinases (MMPs) are thought to be involved in the process of destruction of basement membranes and stromal invasion by neoplastic epithelial cells. AIMS: In order to investigate the role of MMPs in cutaneous oncogenesis we studied the expression of MMP-2 and MMP-9 in 34 cases of epidermal preinvasive neoplastic lesions and invasive carcinomas. We also studied their relationship with the expression of tissue inhibitors of MMPs and with proliferative activity and p53 expression in neoplastic epithelial cells. RESULTS: MMP-9 was found to be focally expressed by neoplastic epithelial cells at the infiltrative edges in microinvasive carcinomas and in dyskeratotic foci in Bowen's disease and widely invasive carcinomas. Gradation of Mib-1 positivity and p53 expression was found with increasing abnormality in the spectrum of malignancy. CONCLUSIONS: Our results seem to suggest the involvement of MMPs in microinvasive carcinomas, which show also low proliferative activity and p53 expression, whether other factors seem to be more important in widely invasive carcinomas.


Subject(s)
Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Skin Neoplasms/pathology , Tumor Suppressor Protein p53/biosynthesis , Aged , Aged, 80 and over , Antigens, Nuclear , Bowen's Disease/enzymology , Bowen's Disease/pathology , Cell Division , Humans , Immunohistochemistry , Ki-67 Antigen , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 9/analysis , Middle Aged , Neoplasm Invasiveness , Nuclear Proteins/analysis , Skin Neoplasms/enzymology , Tissue Inhibitor of Metalloproteinase-1/analysis , Tissue Inhibitor of Metalloproteinase-2/analysis , Tumor Suppressor Protein p53/analysis
12.
Br J Dermatol ; 143(5): 974-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11069505

ABSTRACT

BACKGROUND: The dermal and perivascular infiltrate in dermatitis herpetiformis (DH), which is mainly composed of CD4+ lymphocytes, neutrophils and eosinophils, is believed to play an important part in the pathogenesis of the disease. Previous studies suggest that cytokines such as interleukin (IL) -8, granulocyte-macrophage colony-stimulating factor, IL-4 and IL-5 could be involved in the pathogenesis of DH. These cytokines appear to drive tissue infiltration and maturation of eosinophils. Part of the effect of T-helper (Th) 2-type cytokines (IL-4, IL-5) on eosinophils could be mediated by eotaxin, which is a highly specific chemotactic protein induced by various cytokines [IL-4, IL-13, tumour necrosis factor (TNF) -alpha and interferon-gamma]. OBJECTIVES: To evaluate the expression of eotaxin and its inducers, IL-13 and TNF-alpha, in DH. METHODS We examined lesions collected from 10 DH patients with active disease. Sections from each specimen were incubated with anti-IL-13, anti-TNF-alpha and anti-eotaxin antibodies. Chloroacetyl esterase reaction was performed to show mast cell infiltration. RESULTS: Eotaxin was mainly expressed at the tips of the dermal papillae, within the microabscesses. Positivity was also found in the lymphomonocytic infiltrate in the dermis. IL-13 was expressed in the dermal infiltrate and TNF-alpha was found in the inflammatory infiltrate and in dermal vascular cells. CONCLUSIONS: These findings confirm the importance of the lymphomonocytic infiltrate and of Th2 cytokines in the pathogenesis of this disease, suggesting that tissue infiltration in DH is mediated by cell-specific chemokines such as eotaxin and not only by non-specific chemokines such as IL-8.


Subject(s)
Chemokines, CC , Cytokines/metabolism , Dermatitis Herpetiformis/metabolism , Interleukin-13/metabolism , Tumor Necrosis Factor-alpha/metabolism , Adult , Chemokine CCL11 , Female , Humans , Immunoenzyme Techniques , Male , Middle Aged , Skin/metabolism
14.
Am J Dermatopathol ; 22(3): 264-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10871072

ABSTRACT

We describe two cases of adult rhabdomyoma. One was located in the lip of a 66-year-old woman and was removed because it was clinically suspicious for infiltrating carcinoma. The other arose in the eyelid of a 60-year-old woman with a glass eye and was initially interpreted as a reactive process due to the prosthesis. Both lesions were composed of cells with oval nuclei and deeply eosinophilic cytoplasms with occasional cross striations. Immunoreactivity for desmin and myoglobin excluded the diagnosis of other tumors with similar morphology. The unusual association of the eyelid tumor with the prosthesis suggests a role for chronic irritation in the pathogenesis of rhabdomyoma.


Subject(s)
Eyelid Neoplasms/pathology , Lip Neoplasms/pathology , Rhabdomyoma/pathology , Skin Neoplasms/pathology , Aged , Biomarkers, Tumor/analysis , Eyelid Neoplasms/chemistry , Eyelid Neoplasms/surgery , Female , Humans , Immunoenzyme Techniques , Lip Neoplasms/chemistry , Lip Neoplasms/surgery , Middle Aged , Neoplasm Proteins/analysis , Rhabdomyoma/chemistry , Rhabdomyoma/surgery , Skin Neoplasms/chemistry , Skin Neoplasms/surgery
15.
Haematologica ; 84(9): 809-13, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10477454

ABSTRACT

BACKGROUND AND OBJECTIVE: The early stages of mycosis fungoides (MF) can be treated but not cured by photochemotherapy (PUVA) alone; some recent studies of the effect of a combination of human interferon-alpha (IFN(alpha)) and PUVA reported a high degree of response. The aim of our study was to evaluate the activity of a low dose of IFN-alpha2b combined with PUVA. DESIGN AND METHODS: Twenty-five patients were included: 16 men and 9 women aged between 23-80 years; 19 patients ahd stage I and 6 stage II disease. In the induction phase, the dose of IFNalpha was gradually raised over 6-8 weeks to the target dose of 18 MU/week; in the maintenance phase, the combination with PUVA allowed IFNalpha to be reduced to a maximum dose of 6 MU/week; in this way the cumulative administration of IFNalpha and PUVA was considerably lower than in similar combination protocols. Treatment success was analyzed in terms of freedom from treatment failure (FFTF). RESULTS: After the induction phase 9/25 patients (36%) achieved complete remission (CR) and 15/25 (56%) achieved partial remission (PR). One to five months from the beginning of the maintenance phase, a CR was recorded in 19/25 patients (76%) and a PR in 5/25 patients (20%) accounting for an overall response rate of 96%. The median of FFTF was not reached; probability of FFTF was 82% at 12 months and 62% at 24 months. Disease free survival projected to 48 months was 75%. INTERPRETATION AND CONCLUSIONS: Even with low doses of IFNalpha plus PUVA it is possible to achieve excellent clinical responses,many of which are long-lasting, in patients with early MF.


Subject(s)
Antineoplastic Agents/therapeutic use , Interferon-alpha/therapeutic use , Mycosis Fungoides/drug therapy , PUVA Therapy , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Disease-Free Survival , Female , Humans , Interferon alpha-2 , Male , Middle Aged , Mycosis Fungoides/pathology , Neoplasm Staging , Prospective Studies , Recombinant Proteins , Remission Induction , Treatment Outcome
16.
Cutis ; 59(5): 278-80, 1997 May.
Article in English | MEDLINE | ID: mdl-9169271

ABSTRACT

A 66-year-old man, admitted to the hospital for prostatic carcinoma, presented with a nodular lesion located on the presternal region and a small nodule (0.5 cm in diameter) simulating a scalp sebaceous cyst located on the scalp. Moreover, an irregular darkbrown lesion was observed on the left side of the abdomen, and a brownish macula was also present on the presternal region. Histologic examination of the two nodular lesions revealed cutaneous metastases from prostatic carcinoma. The pigmented lesion, localized on the abdomen, proved to be a superficial spreading melanoma with a maximal depth of 1.36 mm. Histologic examination of the brownish lesion on the presternal region revealed nevus cell nests within the epidermis and in the dermis. We discuss the propensity of developing a secondary cancer in a patient with a primary malignancy.


Subject(s)
Adenocarcinoma/secondary , Melanoma/pathology , Neoplasms, Multiple Primary , Nevus/pathology , Skin Neoplasms/pathology , Skin Neoplasms/secondary , Abdomen , Adenocarcinoma/pathology , Aged , Humans , Lung Neoplasms/secondary , Male , Prostatic Neoplasms/pathology , Scalp , Thorax
17.
Dermatology ; 195(3): 289-92, 1997.
Article in English | MEDLINE | ID: mdl-9407185

ABSTRACT

Lymphoblastic lymphoma (LBL) is a neoplasm of lymphoid precursors presenting usually as acute leukemia with bone marrow and peripheral blood involvement. Primary cutaneous involvement of LBL with a pre-B phenotype has to be considered an extremely uncommon occurrence, accounting for less than 1% of all non-Hodgkin lymphomas. A child with an LBL involving a single cutaneous manifestation of 6 months duration is presented. At the time of presentation, the lesion consisted of a rapidly enlarging deeply infiltrated tumor on the upper arm. Immunophenotypic analysis performed an paraffin-embedded and frozen tissue sections revealed 2 pre-B phenotype of the tumor cells. Similar results were obtained from lymph node and bone marrow biopsy specimens. After 26 months of polychemotherapy, the patient is currently in complete remission. We wish to add this case to the current literature of LBL with cutaneous involvement, emphasizing the importance of a correct diagnosis and the excellent response to the therapeutic regimen.


Subject(s)
Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Skin Neoplasms/pathology , B-Lymphocytes , Drug Therapy, Combination , Female , Humans , Immunophenotyping , Infant , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Remission Induction , Skin Neoplasms/drug therapy
18.
Ann Dermatol Venereol ; 121(4): 319-21, 1994.
Article in French | MEDLINE | ID: mdl-7702251

ABSTRACT

We observed a case of folliculitis decalvans involving the beard and the scalp with a tufted hair folliculitis aspect in the occipital region. The presence of two clinical presentations in the same patient has not been reported in the literature. This would suggest that the two entities could be morphological aspects of the same pathological process which might cause either atrophy with loss or the annexes or tufted hair folliculitis depending upon the depts and destructive capacity of the inflammatory process.


Subject(s)
Folliculitis/pathology , Hair Diseases/pathology , Scalp Dermatoses/pathology , Aged , Humans , Male
19.
Minerva Chir ; 48(11): 649-52, 1993 Jun 15.
Article in Italian | MEDLINE | ID: mdl-8414107

ABSTRACT

The results of a clinico-pathologic and immunohistochemical study of an angiomatoid malignant fibrous histiocytoma are reported. This lesion is an uncommon tumor of the superficial soft tissue, of low-grade malignancy, typical of adolescence and early adult life. The patient, a 10-year-old female, presented with a mass of the left popliteal fossa, treated with surgical excision of the tumor and the surrounding cutaneous and subcutaneous tissue. The tumor was a well-circumscribed, firm nodule measuring 2.5 x 1.0 cm. Histologically, it showed aggregates of spindled and rounded cells often lining cystic cavities filled with blood. The immunohistochemical analysis revealed a cytoplasmatic immunoreactivity for KP1 (CD68), which was taken as indicating that the tumoral mesenchymal cells had acquired phagocytic capacities. The patient is well without signs of local recurrence or metastatic disease 4 years after the surgical treatment. The case reported confirms that appropriate local surgery is the elective therapy for this type of soft tissue tumor.


Subject(s)
Histiocytoma, Benign Fibrous/pathology , Knee , Soft Tissue Neoplasms/pathology , Child , Female , Humans , Immunohistochemistry
20.
Pathologica ; 84(1092): 511-6, 1992.
Article in Italian | MEDLINE | ID: mdl-1491892

ABSTRACT

Granulomatous hepatitis make up a group of conditions of various aetiologies. The diagnosis of granulomatous hepatitis is histologic, since the aspect of the granulomatous lesion is not always indicative of a specific disease. It is important to take into consideration for the aetiologic diagnosis a good response to a specific therapy or the execution of complementary examinations. The 25% of granulomatous hepatitis remain undiagnosed.


Subject(s)
Entamoebiasis/pathology , Granuloma/pathology , Hepatitis/pathology , Liver/pathology , Animals , Antibodies, Protozoan/blood , Child , Entamoeba histolytica/immunology , Entamoebiasis/complications , Entamoebiasis/diagnosis , Entamoebiasis/drug therapy , Female , Fever of Unknown Origin/etiology , Granuloma/parasitology , Hepatitis/parasitology , Humans , Metronidazole/therapeutic use , Necrosis , Suppuration
SELECTION OF CITATIONS
SEARCH DETAIL
...